Work

Lorlatinib: the crown jewel of ALK inhibitors

Year: 2026

Type: editorial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2026.06.014

Authors: A. Rohatgi, R. Govindan

Institution: Washington University in St. Louis

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7166104148

Cites: 12

Cited by:

Related to: 10